Aurélie Rousseau

478 total citations
34 papers, 393 citations indexed

About

Aurélie Rousseau is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, Aurélie Rousseau has authored 34 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 11 papers in Internal Medicine and 5 papers in Genetics. Recurrent topics in Aurélie Rousseau's work include Blood Coagulation and Thrombosis Mechanisms (13 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Pregnancy and preeclampsia studies (5 papers). Aurélie Rousseau is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (13 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Pregnancy and preeclampsia studies (5 papers). Aurélie Rousseau collaborates with scholars based in France, Greece and United States. Aurélie Rousseau's co-authors include Patrick Van Dreden, Rémi Favier, Grigoris Gerotziafas, Marc Vasse, Ismaı̈l Elalamy, Barry Woodhams, Annette K. Larsen, Jean‐Pierre Vannier, Thomas Exner and Pascale Schneider and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Aurélie Rousseau

32 papers receiving 386 citations

Peers

Countries citing papers authored by Aurélie Rousseau

Since Specialization

Citations

This map shows the geographic impact of Aurélie Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Rousseau more than expected).

Fields of papers citing papers by Aurélie Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Rousseau. The network helps show where Aurélie Rousseau may publish in the future.

Co-authorship network of co-authors of Aurélie Rousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Rousseau. A scholar is included among the top collaborators of Aurélie Rousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Rousseau. Aurélie Rousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents 2024 ·Thrombosis Research ·(unknown), Elisabeth Mbemba, (unknown), (unknown), Aurélie Rousseau, Eleftheria Lefkou, Michèle Sabbah, Patrick Van Dreden, Grigoris Gerotziafas	7
2	Circulating Derived Tissue Factor Positive Microparticles and Thrombin Generation a Promising Tool for Identifying Cases at Increased Risk of Thrombotic Complications 2024 ·Blood ·Patrick Van Dreden, Aurélie Rousseau, (unknown), Grigoris Gerotziafas	0
3	Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study 2023 ·Blood ·Patrick Van Dreden, (unknown), Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurélie Rousseau, Michèle Sabbah, (unknown), Ismaı̈l Elalamy, Elisabeth Mbemba, Meletios Α. Dimopoulos, Grigoris Gerotziafas	1
4	Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study 2023 ·Blood ·Patrick Van Dreden, (unknown), Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurélie Rousseau, Michèle Sabbah, (unknown), Elisabeth Mbemba, Ismaı̈l Elalamy, Meletios Α. Dimopoulos, Grigoris Gerotziafas	2
5	Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database 2020 ·Scientific Reports ·Marie Viprey, (unknown), Aurélie Rousseau, Cécile Payet, Roland Chapurlat, Pascal Caillet, Alexandra L. Dima, Anne‐Marie Schott	5
6	Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells 2019 ·Thrombosis Research ·(unknown), Aurélie Rousseau, Annette K. Larsen, Ismaı̈l Elalamy, Patrick Van Dreden, Grigoris Gerotziafas	8
7	Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer 2017 ·International Journal of Oncology ·Aurélie Rousseau, Patrick Van Dreden, (unknown), Annette K. Larsen, Ismaı̈l Elalamy, Grigoris Gerotziafas	22
8	OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa 2016 ·Thrombosis Research ·Grigoris Gerotziafas, Aurélie Rousseau, Patrick Van Dreden, Elisabeth Mbemba, (unknown), (unknown), A. Larsen, Ismaı̈l Elalamy	1
9	Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin 2015 ·Thrombosis Research ·Aurélie Rousseau, Patrick Van Dreden, Elisabeth Mbemba, Ismaı̈l Elalamy, Annette K. Larsen, Grigoris Gerotziafas	15
10	Reconnaître et caractériser les zones de forge sur surface décapée. Apport de la géophysique à l’étude paléométallurgique 2014 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Philippe Lefèvre, Aurélie Rousseau	4
11	Pharmacokinetics and exposure–effect relationships of capecitabine in elderly patients with breast or colorectal cancer 2014 ·Cancer Chemotherapy and Pharmacology ·Zeinab Abdi, Sandrine Lavau‐Denès, Aurélie Prémaud, Saı̈k Urien, François‐Ludovic Sauvage, Jennifer Martin, Sophie Léobon, Pierre Marquet, N. Tubiana-Mathieu, Aurélie Rousseau	14
12	Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability 2014 ·BMC Cancer ·(unknown), (unknown), Aurélie Rousseau, Eleftheria Lefkou, Patrick Van Dreden, (unknown), (unknown), (unknown), (unknown), (unknown), Mounir Frikha, (unknown), Jamel Daoud, Choumous Kallel, Martin Quinn, Joseph Gligorov, Jean Pierre Lotz, Mohamed Hatmi, Ismaı̈l Elalamy, Grigoris Gerotziafas	43
13	Decreased procoagulant phospholipids in patients treated by vitamin K antagonists 2012 ·Thrombosis Research ·Aurélie Rousseau, Barry Woodhams, (unknown), Patrick Van Dreden, (unknown), (unknown), Bernard Lenormand, Marc Vasse	2
14	Decreased activity of soluble thrombomodulin and plasma procoagulant phospholipids in childhood bone marrow transplantation with severe complications 2011 ·Thrombosis Research ·Pascale Schneider, Patrick Van Dreden, Aurélie Rousseau, Aude Marie‐Cardine, Estelle Houivet, Jean‐Pierre Vannier, Marc Vasse	4
15	Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability? 2011 ·Thrombosis Research ·Patrick Van Dreden, Barry Woodhams, Aurélie Rousseau, Marie Favier, Rémi Favier	12
16	Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: New and useful markers for pre-eclampsia? 2009 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Aurélie Rousseau, Rémi Favier, Patrick Van Dreden	56
17	Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction 2009 ·Blood Coagulation & Fibrinolysis ·Patrick Van Dreden, Aurélie Rousseau, Arnaud Savouré, Bernard Lenormand, (unknown), Marc Vasse	30
18	Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia 2009 ·British Journal of Haematology ·Pascale Schneider, Patrick Van Dreden, Aurélie Rousseau, (unknown), Elisabeth Legrand, Jean‐Pierre Vannier, Marc Vasse	37
19	Human Seminal Plasma Fibrinolytic Activity 2007 ·Seminars in Thrombosis and Hemostasis ·Patrick Van Dreden, (unknown), Aurélie Rousseau	7
20	Bayesian Forecasting of Oral Cyclosporin Pharmacokinetics in Stable Lung Transplant Recipients With and Without Cystic Fibrosis 2003 ·Therapeutic Drug Monitoring ·Aurélie Rousseau, Caroline Monchaud, Jean Debord, (unknown), Marc Estenne, (unknown), Pierre Marquet	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact